首页|甲状腺自身抗体与甲状腺乳头状癌患者临床特征及预后的相关性

甲状腺自身抗体与甲状腺乳头状癌患者临床特征及预后的相关性

扫码查看
目的 分析甲状腺自身抗体与甲状腺乳头状癌(PTC)患者临床特征及预后的相关性。方法 将 2019 年1月至2020年12月我院收治的786例PTC患者纳入PTC组,同期收治的352例良性结节性甲状腺囊肿患者纳入良性结节性甲状腺囊肿组。比较两组的甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)阳性率;比较PTC组不同水平TPOAb、TGAb患者的临床特征及生存情况。结果 PTC组的TPOAb、TGAb阳性率高于良性结节性甲状腺囊肿组(P<0。05)。PTC组TPOAb阳性患者的肿瘤直径及淋巴结转移、腺体外播散、脉管侵犯占比明显高于TPOAb阴性患者(P<0。05)。PTC组TGAb阳性患者的肿瘤直径及男性、侵犯包膜、脉管侵犯占比明显高于TGAb阴性患者(P<0。05)。TPOAb、TGAb阳性患者的PTC治疗后转移或复发占比明显高于TPOAb、TGAb阴性患者(P<0。05)。TPOAb、TGAb阳性患者的平均无瘤生存期短于TPOAb、TGAb阴性患者(P<0。05)。结论 TPOAb、TGAb可作为评估PTC患者病情变化及预测预后的有效指标。
Correlation between thyroid autoantibodies and clinical features and prognosis of patients with papillary thyroid carcinoma
Objective To analyze the correlation between thyroid autoantibodies and clinical features and prognosis of patients with papillary thyroid carcinoma(PTC).Methods A total of 786 PTC patients admitted in our hospital from January 2019 to December 2020 were enrolled in PTC group,and 352 benign nodular thyroid cyst patients admitted during the same period were enrolled in benign nodular thyroid cyst group.The positive rates of thyroid peroxidase antibody(TPOAb)and thyroid globulin antibody(TGAb)were compared between the two groups;the clinical features and survival of patients with different levels of TPOAb and TGAb in the PTC group were compared.Results The positive rates of TPOAb and TGAb in the PTC group were higher than those in the benign nodular thyroid cyst group(P<0.05).The tumor diameter and the proportion of lymph node metastasis,extraglandular dissemination and vascular invasion in the TPOAb positive patients were significantly higher than those in the TPOAb negative patients of the PTC group(P<0.05).The tumor diameter and the proportion of male,capsule invasion and vascular invasion in the TGAb positive patients were significantly higher than those in the TGAb negative patients of the PTC group(P<0.05).The proportion of metastasis or recurrence after PTC treatment in the TPOAb and TGAb positive patients were significantly higher than those in the TPOAb and TGAb negative patients(P<0.05).The average disease-free survival time of the TPOAb and TGAb positive patients were shorter than those of the TPOAb and TGAb negative patients(P<0.05).Conclusion TPOAb and TGAb can be used as effective indicators to evaluate the changes of PTC patients and predict the prognosis.

papillary thyroidcar cinomathyroid peroxidase antibodythyroid globulin antibody

王玉艳、魏欣

展开 >

西安凤城医院,陕西 西安,710021

甲状腺乳头状癌 甲状腺过氧化物酶抗体 甲状腺球蛋白抗体

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(34)